09:40 AM EDT, 05/01/2025 (MT Newswires) -- Blueprint Medicines ( BPMC ) reported Q1 earnings Thursday of $0.01 per diluted share, down from $1.40 a year earlier.
Analysts polled by FactSet expected a loss of $0.49 per share.
Revenue for the quarter ended March 31 was $149.4 million, compared with $96.1 million a year earlier.
Analysts surveyed by FactSet expected $155.5 million.
Price: 91.33, Change: +1.83, Percent Change: +2.04